Loopbaan van Loh Chin Siew
Eerdere bekende functies van Loh Chin Siew
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Directeur/Bestuurslid | - | - |
| Singapore Economic Development Board | Corporate Officer/Principal | - | - |
Bio*One Capital Pte Ltd.
 Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Private Equity Investor | - | - |
Opleiding van Loh Chin Siew
| INSEAD | Masters Business Admin |
| University of Bristol | Undergraduate Degree |
Statistieken
Internationaal
| Singapore | 3 |
| Frankrijk | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Consumer Services | 3 |
| Government | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Singapore Economic Development Board | Government |
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
- Beurs
- Insiders
- Loh Chin Siew
- Ervaring
